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There is no doubt that several macro-/microelements and
vitamins are key features to prevent malignancies in
experimental studies on animals. Literature data and
results of our own studies are strongly suggesting that for
malignancies characterized by strong contribution of
inflammatory response to environmental carcinogens such
as lung, colorectal or prostate cancers, penetrance level
can be reduced significantly by selenium supplementation
in sub-group of persons with Se level < 100 µg/l of serum/
plasma. Thus, almost entire Polish population should be
supplemented with Se. It seems that the very important
exception are females with increased risk of breast/ovarian
cancers, because only 40% carries selenoprotein genotypes
in which supplementation can be recommended as the
option. Our center has been realizing prospective studies
validating the above findings and searching for identifica-
tion of similar associations for the large panel of macro-/
microlements and vitamins. The goal is to collect biologi-
c a ls a m p l e s( a tl e a s tD N A sa n ds e r a )f r o mm o r et h a n
20,000 persons, mainly with diagnosed increased risk of
cancers. The whole group will be followed for at least
5 years. Bio-banking and collection of medical information
will be performed annually.
Basic selenium level will be measured for majority of
participants. Selected participants matching require-
ments of other projects will get also results of analyses
of other macro-/microelements and vitamins.
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